35-2 Neuropathic Osteoarthropathy – The Charcot Foot

Current Status
Not Enrolled
Price
$88.00
Get Started

EDITORIAL

» What we know today regarding Charcot neuropathic osteoarthropathy has evolved dramatically. ...

…Thank you to Dr. Lee Sanders for his commitment to research on this condition, and for sharing his experiences from abroad and the findings of Jean Martin Charcot. From conservative measures to surgical management, research pertaining to Charcot neuropathic osteoarthropathy continues to grow to help physicians manage this detrimental pathology. Charcot neuropathic osteoarthropathy is not exclusively found in patients with diabetes, but this is the most common form we see in our practice. The articles selected for this issue are a collective overview of where we began from a historical perspective and the possibilities of reconstruction with surgical management, whether it is internal or external fixation, as well as the location of fixation depending on preoperative evaluation. This edition reviews the history of Jean Martin Charcot, the evolution of how we came to understand this pathology, and how we manage it today.

Lauren L. Schnack, DPM, MS, AACFAS, FACPM


2024 by Data Trace Publishing Company. All rights reserved. Reproduction or translation of any part of this work beyond that permitted by Section 107 or 108 of the United States Copyright Law without the permission of the copyright owner is unlawful. No portion(s) of the work(s) may be reproduced without written consent from Data Trace Publishing Company. Permission to reproduce copies of articles for non-commercial use may be obtained for a fee of $22 per copy from the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400, www.copy right.com.

The ideas and opinions expressed in Foot and Ankle Quarterly are those of the authors and do not necessarily reflect those of the Editor or the Publisher. Publication of an advertisement or other product mentioned in Foot and Ankle Quarterly should not be construed as an endorsement of the product of the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The Publisher does not assume any responsibility for any injury and/or damage to any persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each device or of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other healthcare professionals, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.

Disclosure

Data Trace Publishing Company Continuing Education Mission StatementData Trace Publishing Company is committed to providing high-quality print and internet-based enduring continuing education programs, including lectures, feature articles, and condensations and commentaries on current clinical podiatric topics and medical risk management topics which lead to improved delivery of patient care and help reduce the potential for medical errors. These programs are provided to meet the educational needs of the podiatric medical profession and thereby enhance the quality of patient care.

Program Objectives

Foot and Ankle Quarterly (FAQ) is a unique program designed to help today’s podiatric physician manage an ever-increasing flow of information. After completing the Foot and Ankle Quarterly, Volume 34 program, the learner should be better able to: develop and refine a perspective on current treatment recommendations, updates, and advances pertinent to podiatric practice; evaluate the implications of the learned information as it pertains to the diagnosis and treatment of podiatric disorders and societal issues and barriers, and; apply current trends, standards, and best practices into learner’s own practice.

Data Trace Publishing Company Continuing Education Accreditation Statement

Data Trace Publishing Company is approved by the Council on Podiatric Medical Education (CPME) as a provider of continuing education in podiatric medicine. Data Trace Publishing Company has approved this activity for a maximum of 6 continuing education contact hours (CECHs). Physicians should claim only the contact hours commensurate with the extent of their participation in the activity.

Estimated time to complete activity: 6 hours

Date of release: September 23rd, 2024
Expiration Date: September 23rd, 2027 (unless further validated and extended by provider). For amended dates of activity expiration, please see FAQ Activity Effective Dates at www.datatrace.com).

Commercial Interests

No commercial interest provided financial support for this continuing education activity.

CECH Note

Participants of Volume 34, Issue 3 will receive a maximum of 6 CECHs for a correctly-completed CME Answer Form. In order to qualify for CECHs, a score of 70% or more must be achieved on the written examination material. Any participant who does not pass the first time may take the exam one additional time (within 90 days of receipt of results). One retake test may be taken for a fee of $15. You will be responsible for notifying your state of the number of contact hours you have received.

Participants are required to complete a course evaluation for use in developing future issues and to meet the unique educational needs of podiatric physicians.

FINANCIAL DISCLOSURE INFORMATION

It is the policy of Data Trace Publishing Company to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, presenters, speakers, authors, and reviewers participating in any programs provided by Data Trace Publishing Company are expected to disclose any relevant financial relationships with CPME-defined commercial interests to the program audience. “Relevant financial relationships” are financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any organization manufacturing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The CPME mandates that the content of accredited activities be objective and independent of commercial bias. The intent of this policy is that readers may form their own judgements about the presentations, using independent review to resolve all identified conflicts of interest.

In addition to disclosing commercial relationships, faculty are advised of the following policies:

Each continuing education planner and author has submitted a Conflict of Interest Disclosure in order to identify relevant financial relationships and resolve conflicts.

Limitations on Data: Presenter will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion).

Discussion of Unapproved Uses: If unapproved (unlabeled) uses are discussed during the continuing education activity, the presenter will disclose when a product is not approved in the United States (and/or the nation where the activity takes place) for the use under discussion.

Data Trace Publishing Company has identified the option to disclose as follows:

The following authors have disclosed whether they or a member of their immediate family:

  1. Will be receiving an honorarium for this activity
  2. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author:
    1. Received monetary or other significant research support
    2. Are or had been a paid consultant
    3. Are or had been a full-time or part-time employee
    4. Are or had been a paid or unpaid member of an advisory or similar board
    5. Are or had been a member or on the Board of Trustees
    6. Other
  3. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, BUT will not be recommending any of their products over similar competitor products
  4. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, AND will be recommending one or more of their products over similar competitor products. Recommendation will be based on:
    1. Exclusively on data and/or clinical experience not generated by the manufacturer or derived from manufacturer-sponsored studies
    2. Data and/or clinical experience most of which were not generated by the manufacturer or derived from manufacturer-sponsored studies
    3. Data and/or clinical experience, most of which were generated by the manufacturer or derived from manufacturer-sponsored studies
    4. Exclusively on data and/or clinical experience generated by the manufacturer or derived from manufacturer or derived from manufacturer-sponsored studies
    5. Have no conflicts to disclose

Article Authors and Lecturers

  • Jermaine Als (n.)
  • Ahsana A. Islam (n.)
  • Beth Jarrett (n.)
  • Darrell R. Latva (1. Data Trace Publishing Co.)
  • Remmy S. Owor (n.)
  • Pratibha Patel (n.)
  • Narendra Rajnikant Patel (n.)
  • Adam Phillips (1. Data Trace Publishing Co.)
  • Lauren L. Schnack (1. Data Trace Publishing Co.)
  • Deep N. Shah (n.)
  • Ashka Trivedi (n.)

 FAQ Journal Planning Committee

  • Chrissy Wesolowski (n.)
  • Lauren Molander (n.)
  • Stephanie Wu, DPM, MSc (n.)

Foot and Ankle Quarterly 35-1 Contributors

Guest Editors

Lee J. Sanders, DPM

Lauren L. Schnack, DPM, MS, AACFAS, FACPM

Assistant Professor, Fellowship Trained Podiatric Surgeon, Department of Podiatric Medicine and Surgery, Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science, North Chicago, IL

Contributors

Jermaine Als, DPM
Resident, Department of Surgery, Ascension St. Joseph Hospital, Chicago, IL

Ahsana A. Islam, DPM
Resident Physician, Department of Podiatric Surgery, Ascension Saint Joseph Hospital Chicago, Chicago, IL

Beth Jarrett, DPM
Associate Professor, Department of Podiatric Medicine and Surgery, Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science, North Chicago, IL; Diplomate, American Board of Podiatric Medicine

Darrell R. Latva, DPM
Associate Professor, Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University, North Chicago, IL; Diplomate, American Board of Foot and Ankle Surgery and American Board of Podiatric Medicine

Remmy S. Owor, DPM
Chief Resident Physician,  Podiatric Surgery and Medicine, Ascension Saint Joseph Hospital Chicago, Chicago, IL

Narendra Rajnikant Patel, DPM, FACFAS
Attending Surgeon; St. Joseph’s Residency Program, Chicago, Illinois

Chief of Section of Podiatric Foot and Ankle Surgery at Ascension Alexian Brothers, Elk Grove Village, Illinois

Pratibha Patel, DPM, FACPM
Assistant Professor, Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University, North Chicago, IL; Fellow, American Board of Podiatric Medicine

Adam Phillips, DPM, MPH
Attending Surgeon, Assistant Professor, University of Illinois at Chicago, Chicago, IL

Deep N. Shah DPM, MBA, FACFAS
Assistant Professor, Rosalind Franklin University of Medicine and Science, North Chicago, IL

Ashka Trivedi, DPM
Assistant Professor, Department of Medicine and Science, Rosalind Franklin University of Medicine and Science, North Chicago, IL

Dr. Lee J. Sanders is an internationally-recognized author, lecturer, educator, medical historian and authority on diabetes and the Charcot foot. He is the first and only podiatrist to serve as President for Health Care and Education for the American Diabetes Association. Dr. Sanders is recognized for his research and advocacy efforts addressing diabetes-related amputation, surgical approaches, ulcer prevention and Charcot neuroarthropathy.

In 2002, Dr. Sanders received the Marc Walcott Award for Excellence in Clinical Care Delivery from the Department of Veterans Affairs Veterans Health Administration. In 2004, he co-authored a textbook, A Practical Manual of Diabetic Foot Care, together with Drs. Michael Edmonds and Alethea Foster (London, UK). The British Medical Association Book Competition Awards selected this book as the 2004 Medical Book of the Year.

The University of Texas Health Science Center at San Antonion awarded the Lee J. Sanders Professorship in Lower Extremity Amputation Prevention. In this same year, he was honored by Temple University as a 2007 – 2008 Gallery of Success Inductee.

Dr. Lauren L. Schnack is an Assistant Professor for the Department of Podiatric Medicine and Surgery within the Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science. She is Board Qualified in Foot and Reconstructive Rearfoot and Ankle Surgery by the American Board of Foot and Ankle Surgery, and Board Certified by the American Board of Podiatric Medicine. She completed a CPME-accredited Fellowship at AMITA Health Saint Joseph Hospital Chicago as well as a Podiatric Medicine and Surgery Residency, with the added credential in Reconstructive Rearfoot and Ankle Surgery training at Saint Vincent Charity Medical Center in Cleveland, Ohio.

Dr. Schnack received her Doctor of Podiatric Medicine Degree from Kent State University College of Podiatric Medicine, earned a Master of Science Degree in Medical Physiology from Case Western Reserve University, and a Bachelor of Arts Degree in Anthropology (with a minor in Health Sciences) from Wright State University. She has a passion for all pathology of the lower extremity, especially the utilization of orthoplastics and microneurosurgical techniques, and has been involved with numerous publications, lectures and research projects.


35-2 In this issue:

  • FEATURE ARTICLE: Superconstructs and Advances in Fixation in Reconstruction of Midfoot Charcot
    Darrell R. Latva, DPM, FACFAS, FACPM
  • CONDENSATIONS and COMMENTARIES
    • The Charcot Foot: Historical Perspective 1827 – 2003
      Commentary by Beth Jarrett, DPM
    • Jean-Martin Charcot (1825 – 1893): The Man Behind the Joint Disease
      Commentary by Beth Jarrett, DPM
    • Functional Outcomes of Tibiotalocalcaneal Arthrodesis Using a Hindfoot Arthrodesis Nail in Treating Charcot’s Arthropathy Deformity
      Commentary by Remmy S. Owor, DPM
    • “No Care Pin Care” following Charcot Reconstruction With Static External Fixation
      Commentary by Narendra Rajnikant Patel, DPM, FACFAS
    • Internal Amputation in Charcot Neuroarthropathy Complicated by Diabetic Foot Osteomyelitis
      Commentary by Deep N. Shah, DPM, MBA, ABFAS
    • Acute Hot Foot: Charcot Neuroarthropathy or Osteomyelitis? Untangling a Diagnostic Web
      Commentary by Pratibha Patel, DPM, FACPM
    • Physical Activity Assessment in the Charcot Population
      Commentary by Deep N. Shah, DPM, MBA, FACFAS
    • Progression to Hindfoot Charcot Neuroarthropathy after Midfoot Charcot Correction in Patients with and without Subtalar Joint Arthrodesis
      Commentary by Jermaine Als, DPM
    • Surgical Treatment of Midfoot Charcot Neuroarthropathy with Osteomyelitis in Patients with Diabetes: A Systematic Review
      Commentary by Ahsana A. Islam, DPM
    • A Systematic Review of Intramedullary Fixation in Midfoot Charcot Neuroarthropathy
      Commentary by Ashka Trivedi, DPM
  • AUDIO LECTURE 1: Charcot Neuroarthropathy: History, Etiology, Pathology and Clinical Evaluation
    Adam Phillips, DPM, MPH
  • AUDIO LECTURE 2: Charcot Neuroarthropathy: Complications/Morbidity and Conservative/Surgical Treatment
    Adam Phillips, DPM, MPH